Real-life studies in allergen immunotherapy

被引:12
|
作者
Passalacqua, Giovanni [1 ]
Bagnasco, Diego [1 ]
机构
[1] Univ Genoa, Allergy & Resp Dis, IRCCS Policlin San Martino, Lgo R Benzi 10, I-16133 Genoa, Italy
关键词
allergen immunotherapy; efficacy; real life; real world; safety; RANDOMIZED CONTROLLED-TRIALS; ADVERSE SYSTEMIC REACTIONS; SUBLINGUAL IMMUNOTHERAPY; EUROPEAN SURVEY; ASTHMA; RHINITIS; SAFETY; MANAGEMENT; EFFICACY; EASSI;
D O I
10.1097/ACI.0000000000000757
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Real-life (or real-world) studies can provide information that cannot be derived from randomized controlled trials. This approach is currently becoming of relevance for many treatments. In recent years, the real-life method has been applied also to allergen immunotherapy, providing new insights on it. We reviewed herein the available literature on the argument. Recent findings Several prospective and retrospective studies on allergen immunotherapy in the real-world setting have been published, mostly in the last 5 years. Most of them focused on adverse events, compliance, and the long term/preventive effects, and evidenced an overall favorable profile for different products and different allergens. Real life study provided novel information and evidenced those aspects of immunotherapy that worth a more detailed approach, without the strict limitations usually imposed by controlled randomized trials.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [21] Tablet allergen immunotherapy: the anaphylaxis issue
    Ciprandi, Giorgio
    Naso, Matteo
    Tosca, Maria Angela
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2024, 52 (03) : 73 - 77
  • [22] Dogmas, challenges, and promises in phase III allergen immunotherapy studies
    De Kam, Pieter-Jan
    Kramer, Matthias F.
    Shamji, Mohamed H.
    Oluwayi, Kemi
    Heath, Matthew D.
    Jensen-Jarolim, Erika
    Berger, Markus H.
    Berger, Uwe E.
    Graessel, Anke
    Sellwood, Fiona
    Zielen, Stefan
    Vogelberg, Christian
    Zieglmayer, Petra
    Mosges, Ralph
    Klimek, Ludger
    DuBuske, Lawrence M.
    Shreffler, Wayne G.
    Bernstein, Jonathan A.
    Kundig, Thomas M.
    Skinner, Murray A.
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (09):
  • [23] Development and status of allergen immunotherapy (AIT) for pollen allergy: update 2023
    Gehrt, F.
    Hennighausen, I.
    Bergmann, K. -C.
    Pfaar, O.
    ALLERGOLOGIE, 2023, 46 (09) : 603 - 611
  • [24] Allergen immunotherapy in China
    Yang, Yaqi
    Li, Wenjing
    Zhu, Rongfei
    FRONTIERS IN ALLERGY, 2024, 4
  • [25] Single, pauci, and multi-allergen immunotherapy
    Cingi, C.
    Wise, S. K.
    Lin, S. Y.
    Muluk, N. Bayar
    Franzeses, C. B.
    Rudenko, M.
    Toskala, E.
    Scadding, G. K.
    B-ENT, 2018, 14 (02) : 79 - 84
  • [26] 2019 ARIA Care pathways for allergen immunotherapy
    Bousquet, Jean
    Pfaar, Oliver
    Togias, Alkis
    Schuenemann, Holger J.
    Ansotegui, Ignacio
    Papadopoulos, Nikolaos G.
    Tsiligianni, Ioanna
    Agache, Ioana
    Anto, Josep M.
    Bachert, Claus
    Bedbrook, Anna
    Bergmann, Karl-Christian
    Bosnic-Anticevich, Sinthia
    Bosse, Isabelle
    Brozek, Jan
    Calderon, Moises A.
    Canonica, Giorgio W.
    Caraballo, Luigi
    Cardona, Victoria
    Casale, Thomas
    Cecchi, Lorenzo
    Chu, Derek
    Costa, Elisio
    Cruz, Alvaro A.
    Czarlewski, Wienczyslawa
    Durham, Stephen R.
    Du Toit, George
    Dykewicz, Mark
    Ebisawa, Motohiro
    Fauquert, Jean Luc
    Fernandez-Rivas, Montserrat
    Fokkens, Wytske J.
    Fonseca, Joao
    Fontaine, Jean-Francois
    van Wijk, Roy Gerth
    Haahtela, Tari
    Halken, Susanne
    Hellings, Peter W.
    Ierodiakonou, Despo
    Iinuma, Tomohisa
    Carlos Ivancevich, Juan
    Jacobsen, Lars
    Jute, Marek
    Kaidashev, Igor
    Khaitov, Musa
    Kalayci, Omer
    Tebbe, Joerg Kleine
    Klimek, Ludger
    Kowalski, Marek L.
    Kuna, Piotr
    ALLERGY, 2019, 74 (11) : 2087 - 2102
  • [27] Characteristics of Adverse Reactions and Compliance in Patients who Underwent Allergen-Specific Subcutaneous Immunotherapy; Ten-Year Real-Life Data
    Baccioglu, Ayse
    Kalpaklioglu, Ayse Fusun
    Poyraz, Merve
    Alan Yalim, Sumeyra
    Dumanoglu, Betul
    Alpagat, Gulistan
    ASTIM ALLERJI IMMUNOLOJI, 2022, 20 (01): : 6 - 15
  • [28] Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"
    Paoletti, Giovanni
    Di Bona, Danilo
    Chu, Derek K.
    Firinu, Davide
    Heffler, Enrico
    Agache, Ioana
    Jutel, Marek
    Klimek, Ludger
    Pfaar, Oliver
    Moesges, Ralph
    DunnGalvin, Audrey
    Genuneit, Jon
    Hoffmann, Hans Jurgen
    Canonica, Giorgio Walter
    ALLERGY, 2021, 76 (09) : 2663 - 2672
  • [29] Sublingual allergen immunotherapy for respiratory allergies: what is new?
    Makatsori, Melina
    Calderon, Moises A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (12) : 1641 - 1647
  • [30] Allergen immunotherapy using NPP: Perspectives for the treatment and prevention of respiratory allergies; the case of pollinosis
    Caimmi, D.
    Demoly, P.
    REVUE FRANCAISE D ALLERGOLOGIE, 2019, 59 (08): : 617 - 623